These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
788 related articles for article (PubMed ID: 19544302)
1. Discovery and potency optimization of 2-amino-5-arylmethyl-1,3-thiazole derivatives as potential therapeutic agents for prostate cancer. Krasavin M; Karapetian R; Konstantinov I; Gezentsvey Y; Bukhryakov K; Godovykh E; Soldatkina O; Lavrovsky Y; Sosnov AV; Gakh AA Arch Pharm (Weinheim); 2009 Jul; 342(7):420-7. PubMed ID: 19544302 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213 [TBL] [Abstract][Full Text] [Related]
3. 2-(3-Amino-3-deoxy-beta-D-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity. Popsavin M; Spaić S; Svircev M; Kojić V; Bogdanović G; Popsavin V Bioorg Med Chem Lett; 2006 Oct; 16(20):5317-20. PubMed ID: 16908146 [TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. Gududuru V; Hurh E; Dalton JT; Miller DD J Med Chem; 2005 Apr; 48(7):2584-8. PubMed ID: 15801848 [TBL] [Abstract][Full Text] [Related]
5. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies. Park JH; El-Gamal MI; Lee YS; Oh CH Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063 [TBL] [Abstract][Full Text] [Related]
6. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors. Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and primary cytotoxicity evaluation of new imidazo[2,1-b]thiazole derivatives. Gürsoy E; Güzeldemirci NU Eur J Med Chem; 2007 Mar; 42(3):320-6. PubMed ID: 17145120 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds. Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433 [TBL] [Abstract][Full Text] [Related]
9. New antitumor imidazo[2,1-b]thiazole guanylhydrazones and analogues. Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Zini M; Stefanelli C; Masotti L; Radin NS; Shoemaker RH J Med Chem; 2008 Feb; 51(4):809-16. PubMed ID: 18251494 [TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline. Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848 [TBL] [Abstract][Full Text] [Related]
11. Drug design and testing: profiling of antiproliferative agents for cancer therapy using a cell-based methyl-[3H]-thymidine incorporation assay. Griffiths M; Sundaram H Methods Mol Biol; 2011; 731():451-65. PubMed ID: 21516428 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 4-aryl-4H-chromenes as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 1. Structure-activity relationships of the 4-aryl group. Kemnitzer W; Drewe J; Jiang S; Zhang H; Wang Y; Zhao J; Jia S; Herich J; Labreque D; Storer R; Meerovitch K; Bouffard D; Rej R; Denis R; Blais C; Lamothe S; Attardo G; Gourdeau H; Tseng B; Kasibhatla S; Cai SX J Med Chem; 2004 Dec; 47(25):6299-310. PubMed ID: 15566300 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives. Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents. Lv PC; Li DD; Li QS; Lu X; Xiao ZP; Zhu HL Bioorg Med Chem Lett; 2011 Sep; 21(18):5374-7. PubMed ID: 21802290 [TBL] [Abstract][Full Text] [Related]
15. Substituted thiazoles VII. Synthesis and antitumor activity of certain 2-(substituted amino)-4-phenyl-1,3-thiazole analogs. Hassan GS; El-Messery SM; Al-Omary FA; El-Subbagh HI Bioorg Med Chem Lett; 2012 Oct; 22(20):6318-23. PubMed ID: 22995621 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents. Ando R; Amano Y; Nakamura H; Arai N; Kuwajima I Bioorg Med Chem Lett; 2006 Jun; 16(12):3315-8. PubMed ID: 16617017 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2,5-diaminobenzamide derivatives as anti-proliferating agents. Lee SH; Park JW; Hong JE; Park JW; Lee J Arch Pharm Res; 2009 Jun; 32(6):803-12. PubMed ID: 19557356 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-alpha-aminophosphonates. Jin L; Song B; Zhang G; Xu R; Zhang S; Gao X; Hu D; Yang S Bioorg Med Chem Lett; 2006 Mar; 16(6):1537-43. PubMed ID: 16406612 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of some 2,4,5-trisubstituted thiazole derivatives as potential antimicrobial and anticancer agents. Al-Saadi MS; Faidallah HM; Rostom SA Arch Pharm (Weinheim); 2008 Jul; 341(7):424-34. PubMed ID: 18574850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]